Clinical Trial Update: The Efficacy and Safety of Salmeterol/Fluticasone Propionate vs Atropium/Albuterol in Patients COPD [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing salmeterol/fluticasone propionate to ipratropium/albuterol in COPD to evaluate efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Ipratropium/Albuterol
• Salmeterol/Fluticasone Propionate

Snippet

Sponsor: Fudan University | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 4 | Status: UNKNOWN